Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases

Z S Galis, G K Sukhova, R Kranzhöfer, S Clark, P Libby, Z S Galis, G K Sukhova, R Kranzhöfer, S Clark, P Libby

Abstract

Monocyte-derived foam cells figure prominently in rupture-prone regions of atherosclerotic plaques. Peripheral blood monocytes in culture can produce certain enzymes that degrade extracellular matrix, known as matrix metalloproteinases (MMPs). Lipid-laden macrophages may thus contribute to weakening of extracellular matrix of rupture-prone atherosclerotic plaques. However, the spectrum and regulation of MMP production by foam cells remain unknown. To investigate this issue, we isolated lipid-laden macrophages from rabbit aortic lesions produced by a combination of hypercholesterolemia and balloon injury. Freshly isolated aortic macrophage foam cells, identified using cell-specific antibodies, contained immunoreactive stromelysin and interstitial collagenase, whereas alveolar macrophages isolated from the lungs of same rabbits did not. Macrophages from both tissue sources released gelatinolytic activity consistent with the 92-kDa gelatinase. In vitro, lipid-laden aortic macrophages, but not alveolar macrophages, synthesized de novo and released immunoprecipitable stromelysin and collagenase, with or without stimulation by phorbol ester or bacterial lipopolysaccharide. These stimuli caused foam cells to release additional gelatinolytic activity that migrated faster than a purified preparation of 92-kDa gelatinase in substrate-containing polyacrylamide gels, indicating activation of the 92-kDa gelatinase or induction of the 72-kDa gelatinase. Our results show that lipid-laden macrophages elaborate MMPs capable of degrading the major constituents of vascular extracellular matrix even without further stimulation. Therefore, these cells may contribute to remodeling of the extracellular matrix during atherogenesis and to the disruption of plaques often responsible for acute clinical manifestations of atherosclerosis.

References

    1. J Cell Biol. 1971 Jul;50(1):159-71
    1. Lab Invest. 1977 Sep;37(3):287-96
    1. Am J Pathol. 1979 Apr;95(1):131-58
    1. J Exp Med. 1980 Nov 1;152(5):1340-57
    1. Acta Med Scand Suppl. 1980;642:151-8
    1. J Biol Chem. 1985 Mar 10;260(5):3079-83
    1. Arch Pathol Lab Med. 1985 May;109(5):445-9
    1. Exp Mol Pathol. 1985 Aug;43(1):36-55
    1. J Pathol. 1985 Jul;146(3):197-204
    1. Arteriosclerosis. 1986 Mar-Apr;6(2):131-8
    1. Proc Natl Acad Sci U S A. 1986 Jun;83(11):3756-60
    1. Am J Pathol. 1986 Oct;125(1):191-207
    1. Science. 1988 Jul 8;241(4862):215-8
    1. Circ Res. 1988 Oct;63(4):712-9
    1. J Clin Invest. 1989 Apr;83(4):1174-82
    1. Am J Pathol. 1989 Jul;135(1):169-75
    1. J Clin Invest. 1989 Oct;84(4):1086-95
    1. Lancet. 1989 Oct 21;2(8669):941-4
    1. Am J Cardiol. 1990 Feb 1;65(5):297-302
    1. J Clin Invest. 1990 Nov;86(5):1496-502
    1. J Clin Invest. 1991 Jan;87(1):90-9
    1. J Biol Chem. 1990 Dec 25;265(36):22262-9
    1. J Immunol. 1991 Feb 15;146(4):1286-93
    1. Am J Pathol. 1991 Apr;138(4):1005-14
    1. Arterioscler Thromb. 1991 May-Jun;11(3):745-50
    1. Atherosclerosis. 1991 Mar;87(1):87-90
    1. Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):8154-8
    1. Arterioscler Thromb. 1991 Sep-Oct;11(5):1223-30
    1. Circulation. 1992 Jan;85(1):391-405
    1. Am J Pathol. 1992 Feb;140(2):291-300
    1. Am J Pathol. 1992 Feb;140(2):301-16
    1. Circ Res. 1992 Oct;71(4):850-8
    1. Circulation. 1993 Apr;87(4):1179-87
    1. Circulation. 1994 Jan;89(1):36-44
    1. Circ Res. 1994 Jul;75(1):181-9
    1. J Clin Invest. 1994 Dec;94(6):2493-503

Source: PubMed

3
구독하다